MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $385,457 (100.0% shares, 0.0% debt)

Holdings (33)

CGEM Cullinan Oncology, Inc. 20.9%

Value ($000) $80,689 Shares 7,648,268 Est. Cost $40.60 Unrealized -70.1%

— iTeos Therapeutics, Inc. 8.8%

Value ($000) $34,098 Shares 1,745,943 Est. Cost $24.67 Unrealized —

— Inhibrx, Inc Com 8.2%

Value ($000) $31,698 Shares 1,286,435 Est. Cost $12.67 Unrealized —

— Repare Therapeutics, Inc. 6.3%

Value ($000) $24,122 Shares 1,639,849 Est. Cost $31.02 Unrealized —

— Iveric Bio Inc 5.9%

Value ($000) $22,688 Shares 1,059,688 Est. Cost $17.94 Unrealized —

QURE Uniqure N.V. 5.5%

Value ($000) $21,309 Shares 939,966 Est. Cost $21.57 Unrealized 0.0%

GERN Geron Corporation 5.3%

Value ($000) $20,490 Shares 8,466,981 Est. Cost $1.34 Unrealized +66.9%

NTLA Intellia Therapeutics, Inc. 4.1%

Value ($000) $15,883 Shares 455,238 Est. Cost $87.30 Unrealized -45.5%

— Verve Therapeutics, Inc 4.1%

Value ($000) $15,648 Shares 808,661 Est. Cost $31.14 Unrealized —

RGNX REGENXBIO Inc. 3.7%

Value ($000) $14,093 Shares 621,372 Est. Cost $29.67 Unrealized -23.8%

IOVA Iovance Biotherapeutics Inc Com 3.6%

Value ($000) $13,736 Shares 2,149,550 Est. Cost $11.63 Unrealized -32.9%

— Provention Bio Inc 2.5%

Value ($000) $9,497 Shares 898,483 Est. Cost $5.24 Unrealized —

INSM Insmed Incorporated 2.1%

Value ($000) $8,201 Shares 410,463 Est. Cost $19.33 Unrealized 0.0%

MDGL Madrigal Pharmaceuticals inc 2.0%

Value ($000) $7,771 Shares 26,773 Est. Cost $73.50 Unrealized +33.1%

HRMY Harmony Biosciences Hldgs Inc. 2.0%

Value ($000) $7,680 Shares 139,377 Est. Cost $32.62 Unrealized +68.5%

— Reata Pharmaceuticals inc-a 1.9%

Value ($000) $7,377 Shares 194,181 Est. Cost $33.17 Unrealized —

CRNX Crinetics Pharmaceuticals Inc. 1.8%

Value ($000) $6,801 Shares 371,639 Est. Cost $21.64 Unrealized -18.6%

TVTX Travere Therapeutics Inc. 1.5%

Value ($000) $5,924 Shares 281,711 Est. Cost $18.43 Unrealized +15.0%

HOWL Werewolf Therapeutics, Inc. 1.3%

Value ($000) $4,895 Shares 2,388,011 Est. Cost $13.70 Unrealized -80.9%

FOLD Amicus Therapeutics Inc. 1.3%

Value ($000) $4,889 Shares 400,410 Est. Cost $10.25 Unrealized +9.8%

AXSM Axsome Therapeutics, Inc. 1.0%

Value ($000) $4,009 Shares 51,975 Est. Cost $59.77 Unrealized 0.0%

ARQT Arcutis Biotherapeutics inc 1.0%

Value ($000) $3,879 Shares 262,069 Est. Cost $16.93 Unrealized +3.2%

RVMD Revolution Medicines, Inc. 0.9%

Value ($000) $3,550 Shares 149,043 Est. Cost $28.95 Unrealized -26.5%

— G1 Therapeutics, Inc. 0.9%

Value ($000) $3,530 Shares 650,000 Est. Cost $25.71 Unrealized —

— TCR2 Therapeutics, Inc. 0.9%

Value ($000) $3,368 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Harpoon Therapeutics, Inc. 0.6%

Value ($000) $2,321 Shares 3,196,707 Est. Cost $14.79 Unrealized —

PHAT Phathom Pharmaceuticals inc 0.6%

Value ($000) $2,198 Shares 195,942 Est. Cost $16.08 Unrealized -35.9%

— Chinook Therapeutics, Inc. 0.5%

Value ($000) $2,096 Shares 80,000 Est. Cost $26.20 Unrealized —

— Praxis Precision Medicines Inc. 0.4%

Value ($000) $1,452 Shares 610,000 Est. Cost $2.38 Unrealized —

— Oncorus, Inc. 0.2%

Value ($000) $601 Shares 2,377,031 Est. Cost $32.33 Unrealized —

— AVROBIO, Inc. 0.1%

Value ($000) $462 Shares 647,918 Est. Cost $5.58 Unrealized —

BDTX Black Diamond Therapeutics, Inc. 0.1%

Value ($000) $261 Shares 144,888 Est. Cost $9.87 Unrealized -81.8%

— Inozyme Pharma Inc. 0.1%

Value ($000) $242 Shares 230,500 Est. Cost $7.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$80,689	20.9%	$40.60	-70.1%	Common	230031106
—	iTeos Therapeutics, Inc.	1,745,943	$34,098	8.8%	$24.67	—	Common	46565G104
—	Inhibrx, Inc Com	1,286,435	$31,698	8.2%	$12.67	—	Common	45720L107
—	Repare Therapeutics, Inc.	1,639,849	$24,122	6.3%	$31.02	—	Common	760273102
—	Iveric Bio Inc	1,059,688	$22,688	5.9%	$17.94	—	Common	46583P102
QURE	Uniqure N.V.	939,966	$21,309	5.5%	$21.57	0.0%	Common	N90064101
GERN	Geron Corporation	8,466,981	$20,490	5.3%	$1.34	+66.9%	Common	374163103
NTLA	Intellia Therapeutics, Inc.	455,238	$15,883	4.1%	$87.30	-45.5%	Common	45826J105
—	Verve Therapeutics, Inc	808,661	$15,648	4.1%	$31.14	—	Common	92539P101
RGNX	REGENXBIO Inc.	621,372	$14,093	3.7%	$29.67	-23.8%	Common	75901B107
IOVA	Iovance Biotherapeutics Inc Com	2,149,550	$13,736	3.6%	$11.63	-32.9%	Common	462260100
—	Provention Bio Inc	898,483	$9,497	2.5%	$5.24	—	Common	74374N102
INSM	Insmed Incorporated	410,463	$8,201	2.1%	$19.33	0.0%	Common	457669307
MDGL	Madrigal Pharmaceuticals inc	26,773	$7,771	2.0%	$73.50	+33.1%	Common	558868105
HRMY	Harmony Biosciences Hldgs Inc.	139,377	$7,680	2.0%	$32.62	+68.5%	Common	413197104
—	Reata Pharmaceuticals inc-a	194,181	$7,377	1.9%	$33.17	—	Common	75615P103
CRNX	Crinetics Pharmaceuticals Inc.	371,639	$6,801	1.8%	$21.64	-18.6%	Common	22663K107
TVTX	Travere Therapeutics Inc.	281,711	$5,924	1.5%	$18.43	+15.0%	Common	89422G107
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$4,895	1.3%	$13.70	-80.9%	Common	95075A107
FOLD	Amicus Therapeutics Inc.	400,410	$4,889	1.3%	$10.25	+9.8%	Common	03152W109
AXSM	Axsome Therapeutics, Inc.	51,975	$4,009	1.0%	$59.77	0.0%	Common	05464T104
ARQT	Arcutis Biotherapeutics inc	262,069	$3,879	1.0%	$16.93	+3.2%	Common	03969K108
RVMD	Revolution Medicines, Inc.	149,043	$3,550	0.9%	$28.95	-26.5%	Common	76155X100
—	G1 Therapeutics, Inc.	650,000	$3,530	0.9%	$25.71	—	Common	3621LQ109
—	TCR2 Therapeutics, Inc.	3,370,982	$3,368	0.9%	$14.28	—	Common	87808K106
—	Harpoon Therapeutics, Inc.	3,196,707	$2,321	0.6%	$14.79	—	Common	41358P106
PHAT	Phathom Pharmaceuticals inc	195,942	$2,198	0.6%	$16.08	-35.9%	Common	71722W107
—	Chinook Therapeutics, Inc.	80,000	$2,096	0.5%	$26.20	—	Common	16961L106
—	Praxis Precision Medicines Inc.	610,000	$1,452	0.4%	$2.38	—	Common	74006W108
—	Oncorus, Inc.	2,377,031	$601	0.2%	$32.33	—	Common	68236R103
—	AVROBIO, Inc.	647,918	$462	0.1%	$5.58	—	Common	05455M100
BDTX	Black Diamond Therapeutics, Inc.	144,888	$261	0.1%	$9.87	-81.8%	Common	09203E105
—	Inozyme Pharma Inc.	230,500	$242	0.1%	$7.80	—	Common	45790W108